Recent clinical trial showed higher efficacy and safety with gemcitabine and capecitabine in advanced and metastatic pancreatic cancer patients. In this context, this clinical trials has assessed the safety and efficacy of the gemcitabine and capecitabine in resected pancreatic cancer patients by comparing with gemcitabine monotherapy. Study background In 2012, globally around 338 000 new cases were diagnosed with pancreatic cancer and 331,000 died from pancreatic cancer. Pancreatic cancer is likely to become the second leading cause of cancer mortality in the near future, because of the increased prevalence and the therapies for pancreatic cancer have not been evolved compared to other cancer treatments.
Current treatment regimen includes systemic chemotherapy or combination chemotherapies. In recent years, surgical techniques have also been substantially improved. These advancements…
